These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10936788)
1. Pre-existing histological type and developmental mechanism of mucinous noncystic carcinoma of pancreas. Suda K; Nobukawa B; Yamasaki S; Suzuki F; Shimizu H; Takase M Pathol Oncol Res; 2000; 6(2):125-9. PubMed ID: 10936788 [TBL] [Abstract][Full Text] [Related]
2. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Lüttges J; Zamboni G; Longnecker D; Klöppel G Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467 [TBL] [Abstract][Full Text] [Related]
3. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT). Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444 [TBL] [Abstract][Full Text] [Related]
4. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN. Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063 [TBL] [Abstract][Full Text] [Related]
5. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327 [TBL] [Abstract][Full Text] [Related]
6. Stromal thrombospondin-1 expression is a prognostic indicator and a new marker of invasiveness in intraductal papillary-mucinous neoplasm of the pancreas. Okada K; Hirabayashi K; Imaizumi T; Matsuyama M; Yazawa N; Dowaki S; Tobita K; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H Biomed Res; 2010 Feb; 31(1):13-9. PubMed ID: 20203415 [TBL] [Abstract][Full Text] [Related]
7. Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases. Fukushima N; Mukai K; Sakamoto M; Hasebe T; Shimada K; Kosuge T; Kinoshita T; Hirohashi S Virchows Arch; 2001 Jul; 439(1):6-13. PubMed ID: 11499841 [TBL] [Abstract][Full Text] [Related]
8. Intraductal tubular neoplasms of the pancreas: histogenesis and differentiation. Tajiri T; Tate G; Inagaki T; Kunimura T; Inoue K; Mitsuya T; Yoshiba M; Morohoshi T Pancreas; 2005 Mar; 30(2):115-21. PubMed ID: 15714133 [TBL] [Abstract][Full Text] [Related]
9. Histologic and immunohistochemical comparison of intraductal tubular carcinoma, intraductal papillary-mucinous carcinoma, and ductal adenocarcinoma of the pancreas. Tajiri T; Tate G; Kunimura T; Inoue K; Mitsuya T; Yoshiba M; Morohosh T Pancreas; 2004 Aug; 29(2):116-22. PubMed ID: 15257103 [TBL] [Abstract][Full Text] [Related]
10. Subcellular localization of KL-6 mucin in intraductal papillary mucinous neoplasm of the pancreas. Inagaki Y; Seyama Y; Hasegawa K; Tang W; Kokudo N Drug Discov Ther; 2014 Aug; 8(4):173-7. PubMed ID: 25047009 [TBL] [Abstract][Full Text] [Related]
11. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas. Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580 [TBL] [Abstract][Full Text] [Related]
12. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas. Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573 [TBL] [Abstract][Full Text] [Related]
13. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Adsay NV; Merati K; Basturk O; Iacobuzio-Donahue C; Levi E; Cheng JD; Sarkar FH; Hruban RH; Klimstra DS Am J Surg Pathol; 2004 Jul; 28(7):839-48. PubMed ID: 15223952 [TBL] [Abstract][Full Text] [Related]
14. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010 [TBL] [Abstract][Full Text] [Related]
18. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022 [TBL] [Abstract][Full Text] [Related]
19. Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas. Kashima K; Ohike N; Mukai S; Sato M; Takahashi M; Morohoshi T Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):86-90. PubMed ID: 18234645 [TBL] [Abstract][Full Text] [Related]
20. Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable. Lüttges J; Beyser K; Pust S; Paulus A; Rüschoff J; Klöppel G Mod Pathol; 2003 Jun; 16(6):537-42. PubMed ID: 12808058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]